British Biotech and GeneSoft develop new antibiotics
British Biotech (matrix metalloproteinase inhibitors, MMPIs) and GeneSoft (developing drugs that treat gene-mediated diseases) have signed an agreement to discover and develop anti-infective drugs.
- Includes Equity
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.